tiprankstipranks
Advertisement
Advertisement

Ascend Wellness Resolves Arbitration with $17 Million Settlement

Story Highlights
  • Ascend Wellness resolved a 2018 side letter dispute with Green Thumb Industries via arbitration.
  • The parties settled the $19.7 million award for $17 million, with no expected operational disruption.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Ascend Wellness Resolves Arbitration with $17 Million Settlement

Claim 30% Off TipRanks

The latest update is out from Ascend Wellness Holdings LLC ( ($TSE:AAWH.U) ).

On February 6, 2026, an arbitrator issued an award of approximately $19.7 million in favor of Green Thumb Industries Inc. and TWD18, LLC against Ascend Wellness Holdings, Inc. related to a June 2018 side letter agreement between the parties. On February 11, 2026, Ascend entered into a settlement agreement with the counterparties to fully resolve the arbitration by paying a negotiated amount of $17.0 million, which has been paid in full, extinguishing the award and all related claims without expected material disruption to the company’s ongoing operations.

The most recent analyst rating on ($TSE:AAWH.U) stock is a Buy with a $1.00 price target. To see the full list of analyst forecasts on Ascend Wellness Holdings LLC stock, see the TSE:AAWH.U Stock Forecast page.

More about Ascend Wellness Holdings LLC

Ascend Wellness Holdings, Inc. operates in the U.S. cannabis industry, focusing on the cultivation, manufacturing, and retail sale of cannabis products. The company targets regulated adult-use and medical cannabis markets through vertically integrated operations and branded product offerings.

For an in-depth examination of AAWH.U stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1